(Q45297228)

11 December 2017

title

Proteomic analysis of protein expression and oxidative modification in r6/2 transgenic mice: a model of Huntington disease (English)

1 reference

11 December 2017

0 references

9

D Allan Butterfield

1 reference

11 December 2017

Marzia Perluigi

1

1 reference

11 December 2017

H Fai Poon

2

1 reference

11 December 2017

William Maragos

3

1 reference

11 December 2017

William M Pierce

4

1 reference

11 December 2017

Jon B Klein

5

1 reference

11 December 2017

Vittorio Calabrese

6

1 reference

11 December 2017

Chiara Cini

7

1 reference

11 December 2017

Carlo De Marco

8

1 reference

11 December 2017

publication date

20 June 2005

1 reference

Molecular & Cellular Proteomics

11 December 2017

published in

1 reference

11 December 2017

volume

4

1 reference

11 December 2017

issue

12

1 reference

11 December 2017

page(s)

1849-1861

1 reference

The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500090-MCP200

Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500090-MCP200

Experimental therapeutics in transgenic mouse models of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500090-MCP200

Increased oxidative damage to DNA in a transgenic mouse model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500090-MCP200

Mice transgenic for exon 1 of the Huntington's disease gene display reduced striatal sensitivity to neurotoxicity induced by dopamine and 6-hydroxydopamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500090-MCP200

Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500090-MCP200

Oxidative damage to mitochondrial DNA in Huntington's disease parietal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500090-MCP200

Biochemical abnormalities and excitotoxicity in Huntington's disease brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500090-MCP200

Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500090-MCP200

Oxidative damage and mitochondrial dysfunction in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500090-MCP200

Oxidatively modified proteins in aging and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500090-MCP200

21 January 2018

Oxidative Decay of DNA

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500090-MCP200

Brain oxidative stress in animal models of accelerated aging and the age-related neurodegenerative disorders, Alzheimer's disease and Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500090-MCP200

Reactive oxygen-mediated protein oxidation in aging and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500090-MCP200

Proteomic analysis of protein oxidation in Alzheimer's disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500090-MCP200

Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500090-MCP200

Quantitative proteomics analysis of specific protein expression and oxidative modification in aged senescence-accelerated-prone 8 mice brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500090-MCP200

Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500090-MCP200

Carbonyl assays for determination of oxidatively modified proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500090-MCP200

Proteomics in Alzheimer's disease: insights into potential mechanisms of neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500090-MCP200

The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of Abeta1-42.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500090-MCP200

Hev b 9, an enolase and a new cross-reactive allergen from hevea latex and molds. Purification, characterization, cloning and expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500090-MCP200

Mitochondrial associated metabolic proteins are selectively oxidized in A30P alpha-synuclein transgenic mice--a model of familial Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500090-MCP200

Proteomics for the identification of specifically oxidized proteins in brain: technology and application to the study of neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500090-MCP200

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500090-MCP200

Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500090-MCP200

DNA damage induced by polyglutamine-expanded proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500090-MCP200

Expression of mutant alpha-synuclein causes increased susceptibility to dopamine toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500090-MCP200

Striatal oxidative damage parallels the expression of a neurological phenotype in mice transgenic for the mutation of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500090-MCP200

Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500090-MCP200

Reduction in enkephalin and substance P messenger RNA in the striatum of early grade Huntington's disease: a detailed cellular in situ hybridization study

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500090-MCP200

Decreased expression of striatal signaling genes in a mouse model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500090-MCP200

Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500090-MCP200

Proteomic analysis of 4-hydroxy-2-nonenal-modified proteins in G93A-SOD1 transgenic mice--a model of familial amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500090-MCP200

Structure of the human gene for alpha-enolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500090-MCP200

Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500090-MCP200

Distribution of phosphate-activated glutaminase, succinic dehydrogenase, pyruvate dehydrogenase and gamma-glutamyl transpeptidase in post-mortem brain from Huntington's disease and agonal cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500090-MCP200

Mössbauer studies of beef heart aconitase: evidence for facile interconversions of iron-sulfur clusters

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500090-MCP200

Aconitase is a sensitive and critical target of oxygen poisoning in cultured mammalian cells and in rat lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500090-MCP200

Rapid inactivation of plant aconitase by hydrogen peroxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500090-MCP200

Protein oxidation in aging brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500090-MCP200

Some new aspects of creatine kinase (CK): compartmentation, structure, function and regulation for cellular and mitochondrial bioenergetics and physiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500090-MCP200

Mitochondrial creatine kinase in contact sites: interaction with porin and adenine nucleotide translocase, role in permeability transition and sensitivity to oxidative damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500090-MCP200

Rapid and irreversible inhibition of creatine kinase by peroxynitrite

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500090-MCP200

Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500090-MCP200

Oligomeric state and membrane binding behaviour of creatine kinase isoenzymes: implications for cellular function and mitochondrial structure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500090-MCP200

Oxidative modification of creatine kinase BB in Alzheimer's disease brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500090-MCP200

Creatine therapy provides neuroprotection after onset of clinical symptoms in Huntington's disease transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500090-MCP200

Creatine increase survival and delays motor symptoms in a transgenic animal model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500090-MCP200

In vitro effects of polyglutamine tracts on Ca2+-dependent depolarization of rat and human mitochondria: relevance to Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500090-MCP200

Quantitative evaluation of the effects of mitochondrial permeability transition pore modifiers on accumulation of calcium phosphate: comparison of rat liver and brain mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500090-MCP200

Role of heat shock proteins during polyglutamine neurodegeneration: mechanisms and hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500090-MCP200

Mutant Cu/Zn-superoxide dismutase proteins have altered solubility and interact with heat shock/stress proteins in models of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500090-MCP200

Geldanamycin activates a heat shock response and inhibits huntingtin aggregation in a cell culture model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500090-MCP200

Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease progression in ALS mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500090-MCP200

Functional aspects of the X-ray structure of mitochondrial creatine kinase: a molecular physiology approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500090-MCP200

Octamer-dimer Transitions of Mitochondrial Creatine Kinase in Heart Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500090-MCP200

10.1074/MCP.M500090-MCP200

21 January 2018

Identifiers

DOI

1 reference

11 December 2017

1 reference